Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer-Reference-Cited by-同舟云学术

Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer

Published:2023-10 Issue: Volume:301 Page:122280
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Vicente-Ruiz Sonia^ORCID,Armiñán Ana,Maso Katia^ORCID,Gallon Elena,Zagorodko Oleksandr^ORCID,Movellan Julie^ORCID,Rodríguez-Otormín Fernanda^ORCID,Baues Maike,May Jan-Niklas^ORCID,De Lorenzi Federica,Lammers Twan^ORCID,Vicent María J.^ORCID

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference48 articles.

1. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis;Lucas;Cancer Discov.,2014

2. Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy;Wu;Cancer Metastasis Rev.,2014

3. ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents;Mancarella;Oncotarget,2017

4. Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors;Macaulay;Ann. Oncol.,2013

5. A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer;Chi;Clin. Cancer Res.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancement in Mechanistic Alteration of IGFs Family of Receptors to Target Prostate and Cervical Cancer: An Updated Review;Current Cancer Therapy Reviews;2024-08-19

2. Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy;ACS Biomaterials Science & Engineering;2024-06-08

3. Conformation-Switchable Polypeptides as Molecular Gates for Controllable Drug Release;Biomacromolecules;2024-05-07

4. Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques;Advanced Drug Delivery Reviews;2024-04

5. Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications;Pharmaceutics;2024-02-20